<DOC>
	<DOCNO>NCT00307463</DOCNO>
	<brief_summary>This study aim mainly investigate effect two approach control blood pressure hypertensive hemodialysis patient ; use antihypertensive drug versus strict volume control ( strict dietary salt restriction persistent ultrafiltration ) without use antihypertensive drug cardiac structure inflammation .</brief_summary>
	<brief_title>Effects Strict Volume Control Hypertensive Hemodialysis Patients Cardiac Structure Chronic Inflammation</brief_title>
	<detailed_description>This randomise , control prospective study aim mainly investigate effect two approach control blood pressure hypertensive hemodialysis patient ; use antihypertensive drug versus persistent strict volume control without use antihypertensive drug cardiac structure ( mainly leave ventricular hypertrophy ) inflammation . We hypothesize well blood pressure control regression leave ventricular mass may reach policy strict volume control consist strict dietary salt restriction persistent ultrafiltration . 258 Hypertensive hemodialysis patient ( BP &gt; 130/80 mmHg and/or antihypertensive medication ) randomize two arm : Group 1 : Antihypertensive medicine stop strict volume control policy apply . Group 2 : Antihypertensive medicine continue . Target BP 130/80 mmHg group . The patient evaluate 12 month primary outcome . Primary end-points significant change leave ventricular hypertrophy leave ventricular mass significant change leave ventricular end-diastolic volume . Secondary end-points change post-dialysis weight , change hematocrit , albumin , BNP hsCRP level .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<criteria>age 1870 year old maintenance bicarbonate hemodialysis schedule thrice weekly , least 12 hours/week willingness participate study write informed consent . schedule live donor renal transplantation serious lifelimiting comorbid situation ; namely active malignancy , active infection , endstage cardiac , pulmonary , hepatic disease ; pregnancy lactating</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>end-stage renal disease</keyword>
	<keyword>hemodialysis</keyword>
	<keyword>volume control</keyword>
	<keyword>ultrafiltration</keyword>
	<keyword>inflammation</keyword>
	<keyword>cardiovascular disease</keyword>
	<keyword>leave ventricular hypertrophy</keyword>
	<keyword>dietary salt restriction</keyword>
</DOC>